Citas
WHO. International Classification of Diseases 11th Revision [internet]. 2018 [acesso em: 9 maio 2021]. Disponível em: https://icd.who.int/en
Ministério da Saúde. Secretaria de Gestão Estratégica e Participativa Departamento de Apoio à Gestão Participativa. Política Nacional de Saúde Integral de Lésbicas, Gays, Bissexuais, Travestis e Transexuais. Brasília (DF); 2013.
Spizzirri G, Eufrásio R, Lima MCP, de Carvalho Nunes HR, Kreukels BPC, Steensma TD, et al. Proportion of people identified as transgender and non-binary gender in Brazil. Sci Rep. 26 de janeiro de 2021;11(1):2240.
Besse M, Lampe NM, Mann ES. Experiences with Achieving pregnancy and giving birth among transgender men: a narrative literature review. Yale J Biol Med. set. 2020;93(4):517-28.
Brandt JS, Patel AJ, Marshall I, Bachmann GA. Transgender men, pregnancy, and the “new” advanced paternal age: a review of the literature. Maturitas. 1out. 2019;128:17-21.
Okano SHP, Franceschini SA, Lerri MR, Poli-Neto OB, Brito LGO, Lara LA da S. Characteristics of a population with gender incongruence assisted at a specialized outpatient service in the city of Ribeirão Preto. Rev Bras Ginecol Obstet. 9 fev. de 2022;44(3):258-263.
Pinto MJC, Bruns MA de T. Vivência transexual: o corpo desvela seu drama. Campinas(SP): Átomo; 2004.
Brasil. Ministério da Saúde. Portaria GM n. 1.707, de 18 de agosto de 2008. Institui, no âmbito do Sistema Único de Saúde (SUS), o processo transexualizador, a ser implantado nas unidades federadas, respeitadas as competências das três esferas de gestão. Brasília (DF); 2018.
Conselho Federal de Medicina. Resolução CFM nº 1.955, de 12 de agosto de 2010. Dispõe sobre a cirurgia de transgenitalismo e revoga a Resolução CFM nº 1.652/2002. Diário Oficial da União. 3 set 2010.
Conselho Federal de Medicina. Resolução CFM nº 2.265, 20 de setembro de 2019. Dispõe sobre
o cuidado específico à pessoa com incongruência de gênero ou transgênero e revoga a Resolução
CFM nº 1.955/2010. Diário Oficial da União. 9 jan 2020; Seção I:96.
Brasil. Decreto no 8727, de 28 de abril de 2016. Dispõe sobre o uso do nome social e o reconhecimento da identidade de gênero de pessoas travestis e transexuais no âmbito da administração pública federal direta, autárquica e fundacional [internet]. Diário Oficial da União. 29 abr 2016 [acesso em: 24 abr 2022]. Disponível em: http://www.planalto.gov.br/ccivil_03/_ato2015- 2018/2016/decreto/d8727.htm
Banco Mundial. Enfrentando o desafio das doenças não transmissíveis no Brasil [relatório no 32576- BR]. Brasília: Unidade de Gerenciamento do Brasil; 2005.
Okano SHP, Pellicciotta GGM, Braga GC. Contraceptive Counseling for the transgender patient assigned female at birth. RBGO. abr 2022. No prelo.
Buchting FO, Emory KT, Scout null, Kim Y, Fagan P, Vera LE et al. Transgender use of cigarettes, cigars, and e-cigarettes in a national study. Am J Prev Med. jul 2017;53(1):e1-7.
Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH et al. Endocrine Treatment of gender dysphoric/gender-incongruent persons: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 1 nov 2017;102(11):3869-903.
Fighera TM, da Silva E, Lindenau JDR, Spritzer PM. Impact of cross-sex hormone therapy on bone mineral density and body composition in transwomen. Clin Endocrinol. 1 jun 2018;88(6):856-62.
Brasil. Ministério da Saúde. Política Nacional de Atenção Integral à Saúde da Mulher Princípios e Diretrizes. Brasília (DF); 2004. (Série C. Projetos, Programas e Relatórios).
Kerr-Corrêa F, Pinheiro FML, Martins TA, Costa DL da C, Macena RHM, Mota RMS, et al. Hazardous alcohol use among transwomen in a Brazilian city [internet]. Cad Saúde Pública. 3 abr 2017;33(3):e00008815 [acesso em: 19 set 2021]. Disponível em: http://www.scielo.br/j/csp/a/QdGzrX8jQFyByzD6wKhHXbr/?lang=en
Day JK, Fish JN, Perez-Brumer A, Hatzenbuehler ML, Russell ST. Transgender youth substance use disparities: results from a population-based sample. J Adolesc Health. dez 2017;61(6):729-35.
World Health Organization. Medical eligibility criteria for contraceptive use. Fifth edition. 5o ed.
WHO; 2015.
Curtis KM. U.S. Medical Eligibility Criteria for Contraceptive Use, 2016 [internet]. MMWR Recomm Rep. 2016; 65(3);1-104 [acesso em: 9 maio 2021]. Disponível em: https://www.cdc.gov/mmwr/volumes/65/rr/rr6503a1.htm
Vieira RC, Borret RH. Mulheres cis lésbicas. In: Saúde LGBTQIA+ - Práticas de cuidado transdisciplinar. Santana do Parnaíba (SP): Malone; 2021. p. 211.
Gorgos LM, Marrazzo JM. Sexually transmitted infections among women who have sex with women. Clin Infect Dis. dez 2011;53 Suppl 3:S84-91.
Pinto VM, Tancredi MV, Tancredi Neto A, Buchalla CM. Sexually transmitted disease/HIV risk behaviour among women who have sex with women. AIDS. 2005 Oct;19 Suppl 4:S64-9.
Wang XF, Norris JL, Liu YJ, Reilly KH, Wang N. Health-related attitudes and risk factors for sexually transmitted infections of Chinese women who have sex with women. Chin Med J. ago2012;125(16):2819-25.
Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Imunização e Doenças Transmissíveis. Coordenação-Geral do Programa Nacional de Imunizações. Ofício nº 203/2021/ CGPNI/DEIDT/SVS/MS Brasília; 3 mar 2021.
Leentvaar-Kuijpers A, Kool J, Veugelers P, Coutinho R, Van Griensven G. An outbreak of hepatitis a among homosexual men in amsterdam, 1991-1993. Int J Epidemiol. 1995 Feb;24(1):218-22.
Brook MG. Sexual transmission and prevention of the hepatitis viruses A-E and G. Sex Transm Infect. 1998 Dec;74(6):395-8.
Cáceres CF, O’Reilly KR, Mayer KH, Baggaley R. PrEP implementation: moving from trials to policy and practice. J Int AIDS Soc. 2015;18(4S3):20222.
Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010 Dec;363(27):2587-99.
Li P, Yuan T, Fitzpatrick T, Smith K, Zhao J, Wu G et al. Association between rectal douching and HIV and other sexually transmitted infections among men who have sex with men: a systematic review and meta-analysis. Sex Transm Infect. 2019;95(6):428-36.
Institute of Medicine. The health of lesbian, gay, bisexual, and transgender people: building a foundation for better understanding [internet]. Washington (DC): The National Academies Press; 2011 [acesso em: 12 maio 2021]. Disponível em: https://www.nap.edu/catalog/13128/the-healthof- lesbian-gay-bisexual-and-transgender-people-building
Marrazzo JM, Koutsky LA, Kiviat NB, Kuypers JM, Stine K. Papanicolaou test screening and prevalence of genital human papillomavirus among women who have sex with women. Am J PublicHealth. 2001;91(6):947-52.
Robinson K, Galloway KY, Bewley S, Meads C. Lesbian and bisexual women’s gynaecological conditions: a systematic review and exploratory meta-analysis. BJOG. 2017;124(3):381-92.
Peitzmeier SM, Khullar K, Reisner SL, Potter J. Pap test use is lower among female-to-male patients than non-transgender women. Am J Prev Med. 2014;47(6):808-12.
ACOG. Health care for transgender and gender diverse individuals: ACOG Committee Opinion, Number 823. Obstet Gynecol. 2021 Mar;137(3):e75-e88.
Chen CC, Chou YY. Predictive value of the anal cytology for detecting anal intraepithelial neoplasia or worse: A systematic review and meta-analysis. Diagn Cytopathol. 2019;47(4):307-14.
Albuquerque A, Rios E, Schmitt F. Recommendations favoring anal cytology as a method for anal cancer screening: a systematic review. Cancers (Basel). 2019 Dec 4;11(12):1942.
Hartley RL, Stone JP, Temple-Oberle C. Breast cancer in transgender patients: a systematic review. Part 1: Male to female. Eur J Surg Oncol. 2018 Oct;44(10):1455-62.
Stone JP, Hartley RL, Temple-Oberle C. Breast cancer in transgender patients: a systematic review. Part 2: Female to male. Eur J Surg Oncol. 2018 Oct;44(10):1463-8.
Brown GR, Jones KT. Incidence of breast cancer in a cohort of 5,135 transgender veterans. Breast Cancer Res Treat. 2015;149(1):191-8.
Maglione KD, Margolies L, Jaffer S, Szabo J, Schmidt H, Weltz C et al. Breast cancer in maleto- female transsexuals: use of breast imaging for detection. AJR Am J Roentgenol. 2014Dec;203(6):W735-40.
Asscheman H, Giltay EJ, Megens JAJ, de Ronde WP, van Trotsenburg MAA, Gooren LJG. A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones. Eur J Endocrinol. 2011 Apr;164(4):635-42.
van Kesteren PJ, Asscheman H, Megens JA, Gooren LJ. Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clin Endocrinol. 1997 Sept;47(3):337-42.
Jakub JW, Peled AW, Gray RJ, Greenup RA, Kiluk JV, Sacchini V et al. Oncologic safety of prophylactic nipple-sparing mastectomy in a population with BRCA mutations: a multi-institutional study. JAMA Surg. 2018;153(2):123-9.
Trum HW, Hoebeke P, Gooren LJ. Sex reassignment of transsexual people from a gynecologist’s and urologist’s perspective. Acta Obstet Gynecol Scand. 2015;94(6):563-7.
Instituto Nacional de Câncer José Alencar Gomes da Silva. Detecção precoce do câncer. Rio de Janeiro; 2021.
Trum HW, Hoebeke P, Gooren LJ. Sex reassignment of transsexual people from a gynecologist’s and urologist’s perspective. Acta Obstet Gynecol Scand. 2015 Jun;94(6):563-7.
Lucassen MF, Stasiak K, Samra R, Frampton CM, Merry SN. Sexual minority youth and depressive symptoms or depressive disorder: A systematic review and meta-analysis of population-based studies. Aust N Z J Psychiatry. 2017;51(8):774-87.
Branquinho B, Benedito L, Ciasca S. Síndrome depressivas e ansiosas. iN: Saúde LGBTQIA+: práticas de cuidado transdisciplinar. Santana da Parnaíba (SP): Manole; 2021. p. 390.
Heylens G, Elaut E, Kreukels BPC, Paap MCS, Cerwenka S, Richter-Appelt H et al. Psychiatric characteristics in transsexual individuals: multicentre study in four European countries. Br J Psychiatry. 2014;204(2):151-6.
Blosnich JR, Brown GR, Shipherd JC, Kauth M, Piegari RI, Bossarte RM. Prevalence of gender identity disorder and suicide risk among transgender veterans utilizing veterans health administration care. Am J Public Health. 2013;103(10):e27-e32.
Brancaleoni APL, Amorim SMG, Oliveira RR de. Na construção dos corpos: tecendo saberes sobre a redução de danos junto a travestis. Revista Periódicus. 6 jun 2018;1(9):456-78.
Conselho Federal de Medicina. Resolução nº 2.294, de 27 de maio de 2021. Adota as normas éticas para a utilização das técnicas de reprodução assistida e revoga a Resolução CFM nº 2.168/2017. Diário Oficial da União, 5 jun 2021;Seção 1:602021.
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Derechos de autor 2022 Sérgio Henrique Pires Okano